This antibody has been used to specifically target CCR2+ monocyte subsets in models of toxoplasmosis [28], arthritis [29, 30] and gram negative bacterial meningitis [31]. Here, CCR2 is linked to bacterial meningitis caused by gram-negative bacteria.